Kaohoon’s Top News on June 21, 2021
Top news from “Kaohoon Turakij Newspaper” to start the trading day on June 21, 2021.
– 1 million China’s Sinopharm Covid-19 vaccine doses arrived in Thailand Sunday (June 20). The Chulabhorn Royal Academy will begin the vaccine distribution to organizations and companies nationwide that have registered to obtain vaccines on June 23-24, 2021 before roll-out on June 25, 2021. As of Sunday, Thailand has administered 7.58 million doses of vaccine. Analysts expect the SET Index is at risk to move below 1,600 points this week and maintain the recommendation on city reopening stocks, especially BEM, VGI, PLANB, CRC and HMPRO.
– NR Instant Produce (NRF) expects to attract more domestic and international institutions after being included in the SET100 Index. The company believes that revenue would exceed 3 billion baht in 2022, allowing them to meet the target earlier than previously estimated in 2023. This is due to the positive sentiment towards plant-based protein food products following the Covid-19 pandemic. Additionally, in the second half of 2021, NRF expects to launch a new hemp-based cookie business line.
– Gunkul Engineering (GUNKUL) closed 14.55% higher on Friday (June 18, 2021) with a trading value of over 6,193 million baht following the acquisition of GUNKUL shares by three major investors, including Sura Khanittaweekul and Phongsak Thamthachaaree, in big lot transactions. Analysts anticipate that GUNKUL will receive further permits for hemp cultivation over the next two weeks.
– Intermedical Care and Lab Hospital (IMH) has been selected to serve as one of vaccination centres for China’s Sinopharm vaccine roll-out. The immunization d-day is June 25, 2021. According to the company, over 35,000 people have registered to get the Sinopharm vaccine.
– Jasmine International (JAS) has been added to the cash balance measure, effective today (June 21, 2021), following a recent surge in the share price with a high trading value. Meanwhile, the SET announced that ADD, MACO, SEAOIL, SIMAT, and IMH met the market surveillance criteria for a cash balance measure as well.
